Methylphenidate Hydrochloride

็›้…ธๅ“Œ็”ฒ้…ฏ

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameMethylphenidate Hydrochloride
Drug Alias NameDexmethylphenidate hydrochloride (Rec INNM็›้…ธๅ“Œ้†‹็”ฒ้…ฏ็›้…ธๅ“Œ้†›็”ฒ้…ฏmethylphenidatum hydrochloridum็›้…ธ็”ฒๅ“Œ้…ฏ +[33]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsApathy in DementiaCNS Embryonal TumorSolid tumours +[44]ย 
Global Approved IndicationsAttention Deficit Disorder with HyperactivityNarcolepsy
Approved Indications in ChinaAttention Deficit Disorder with HyperactivityNarcolepsy
Original Approved Country/TerritoryUnited States
Original Approved Date1955/12/05
Country/TerritoryBelgiumCanadaUnited States +[26]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNoven Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSandozSunnybrook Research InstitutePediatrix Therapeutics +[22]ย 
Inactive CompaniesOrient Pharma Co LtdUtah State UniversityDana-Farber Cancer Institute +[48]ย 
Active IndicationsApathy in DementiaPsychotic DisordersBorderline Personality Disorder +[21]ย 
Inactive IndicationsCNS Embryonal TumorSolid tumoursStress Disorders, Post-Traumatic +[23]ย 

Other Information

ATC CodeN06BA04
Related LinksWikipediaDrugBankKEGG